Clicky

Biohit Oyj B(BIOBV)

Description: Biohit Oyj, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. The company's diagnostic tests product range includes the GastroPanel test for diagnosing diseases of the stomach and associated risks; Biohit Active B12, a test for measuring the levels of active vitamin B12; Biohit Total, an indicator of vitamin D status; Biohit Calprotectin, a test for measuring human calprotectin; Helicobacter Pylori Quick Test and Helicobacter Pylori UFT300 Quick Test, a test methods to detect H. pylori infection from a biopsy sample during gastroscopy; ColonView Quick Test, a test for detection of fecal occult blood; Lactose Intolerance Quick Test; Celiac Disease Quick Test; and The GA-map Dysbiosis test, a gut microbiota DNA analysis tool. It also provides monoclonal antibodies for use in cellular pathology, neurobiology, oncology, and human gastric biomarkers research. In addition, the company offers acetaldehyde binding products, such as Acetium capsules that are intended for persons with a low-acid or anacidic stomach; and Acetium lozenges, which removes acetaldehyde in smoker's saliva. Further, it provides microplate readers and strip washers, quick test readers, and ThunderBolt, an automated immunoassay analyzer; and products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies, and service laboratory services. The company was founded in 1988 and is headquartered in Helsinki, Finland.


Keywords: Medicine Biotechnology Disease Antibodies Diagnostic Tests Healthcare Industries Helicobacter Pylori Abdomen

Home Page: www.biohithealthcare.com

Laippatie 1
Helsinki, 00880
Finland
Phone: 358 9773 861


Officers

Name Title
Prof. Osmo Antero Suovaniemi M.D., Ph.D. Founder, Deputy CEO, Member of Scientific Advisory Board & Director
Mr. Jussi Hahtela Chief Exec. Officer
Mr. Jussi Sorvo Chief Financial Officer
Mr. Panu Hendolin Ph.D. Head of Technical Product Management & Member of Management Board
Mr. Ilari Patrakka Director of Sales & Marketing
Mr. Yulia Kubacheva Head of Diagnostics Department - Biohit Russia
Graham Johnson Managing Director of Biohit Healthcare Ltd - UK

Exchange: HE

Country: FI

Currency: Euro (€)

Forward PE: 0
Trailing PE: 60.8333
Price-to-Book MRQ: 3.2792
Price-to-Sales TTM: 2.1595
IPO Date:
Fiscal Year End: December
Full Time Employees: 44
Back to stocks